Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

Kees Hovingh Articles

ISA 2015: PCSK9 inhibitors effective in mixed dyslipidaemia

ISA 2015: PCSK9 inhibitors effective in mixed dyslipidaemia

Treatment with evolocumab or alirocumab was as effective in high risk patients with mixed dyslipidaemia, as in patients solely with elevated low-density lipoprotein (LDL) cholesterol, according to two reports at ISA 2015. Dr Kees Hovingh, Academic Medical Center, Amsterdam, the Netherlands discussed data from an…

read more »
FH – the challenges for the next 10 years?

FH – the challenges for the next 10 years?

Kees Hovingh, Academic Medical Center, Amsterdam, the Netherlands In a session on familial hypercholesterolaemia (FH, inherited high cholesterol) at the 83rd Annual Congress of the European Atherosclerosis Society (EAS), Dr Kees Hovingh outlined what he saw as the challenges for FH in the next decade….

read more »